F-18-fluorodeoxyglucose PET imaging alters clinical decision making in patients with impaired ventricular function.
The effect of F-18-fluorodeoxyglucose positron emission tomography imaging on decision making in the selection of patients with impaired ventricular function for revascularization was determined in 87 patients. In 57% of patients, positron emission tomography data influenced management decisions, indicating an important effect of myocardial viability determination on difficult therapy decisions in these patients.
Beanlands
R S
RS
Cardiac PET Centre, University of Ottawa Heart Institute, Ontario, Canada.
deKemp
R A
RA
Smith
S
S
Johansen
H
H
Ruddy
T D
TD
D000368:Aged; D003327:Coronary Disease / Q000150:complications / Q000000981:diagnostic imaging / Q000378:metabolism / Q000601:surgery*; D003657:Decision Making; D003847:Deoxyglucose / Q000031:analogs & derivatives*; D005260:Female; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D008875:Middle Aged; D009204:Myocardial Revascularization; D009206:Myocardium / Q000378:metabolism*; D011446:Prospective Studies; D014055:Tomography, Emission-Computed / Q000379:methods; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging* / Q000209:etiology / Q000378:metabolism / Q000601:surgery
D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose